QT IMAGING HOLDINGS, INC. Research and Development Expense
QT IMAGING HOLDINGS, INC. (QTI) reported Research and Development Expense of $1.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-12
- QT IMAGING HOLDINGS, INC. research and development expense for the quarter ending 2026-06-30 was $1.62M, a 80.24% increase year-over-year.
- QT IMAGING HOLDINGS, INC. research and development expense for the quarter ending 2026-03-31 was $1.72M, a 102.35% increase year-over-year.
- QT IMAGING HOLDINGS, INC. research and development expense for the quarter ending 2025-12-31 was $1.24M, a 60.73% increase year-over-year.
- QT IMAGING HOLDINGS, INC. research and development expense for the quarter ending 2025-09-30 was $938.76K, a 1.46% increase year-over-year.
- QT IMAGING HOLDINGS, INC. research and development expense for fiscal 2025 was $3.94M, a 20.48% increase from fiscal 2024.
- QT IMAGING HOLDINGS, INC. research and development expense for fiscal 2024 was $3.27M, a 119.91% increase from fiscal 2023.
- QT IMAGING HOLDINGS, INC. research and development expense for fiscal 2023 was $1.49M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.62M 10-Q · filed 2026-08-12 | $3.35M 10-Q · filed 2026-08-12 | $4.59M derived: sum of 3 quarters · filed 2026-08-12 | $5.53M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $1.72M 10-Q · filed 2026-05-13 | $2.97M derived: sum of 2 quarters · filed 2026-05-13 | $3.91M derived: sum of 3 quarters · filed 2026-05-13 | $4.81M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.18M derived: sum of 2 quarters · filed 2026-03-25 | $3.08M derived: sum of 3 quarters · filed 2026-08-12 | $3.94M 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $938.76K 10-Q · filed 2025-11-12 | $1.84M derived: sum of 2 quarters · filed 2026-08-12 | $2.69M 10-Q · filed 2025-11-12 | $3.47M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | $901.00K 10-Q · filed 2026-08-12 | $900.69K 10-Q · filed 2025-08-07 | $1.75M 10-Q · filed 2026-08-12 | $1.75M 10-Q · filed 2025-08-07 | $2.53M derived: sum of 3 quarters · filed 2026-08-12 | $3.45M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $852.00K 10-Q · filed 2026-05-13 | $852.25K 10-Q · filed 2025-05-13 | $1.63M derived: sum of 2 quarters · filed 2026-05-13 | $2.55M derived: sum of 3 quarters · filed 2026-05-13 | $3.48M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $774.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.70M derived: sum of 2 quarters · filed 2026-03-25 | $2.62M derived: sum of 3 quarters · filed 2026-03-25 | $3.27M 10-K · filed 2026-03-25 | $3.27M 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $925.21K 10-Q · filed 2025-11-12 | $1.85M derived: sum of 2 quarters · filed 2025-11-12 | $2.49M 10-Q · filed 2025-11-12 | $2.90M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $925.08K 10-Q · filed 2025-08-07 | $1.57M 10-Q · filed 2025-08-07 | $1.97M derived: sum of 3 quarters · filed 2025-08-07 | $2.28M derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $642.55K 10-Q · filed 2025-05-13 | $1.04M derived: sum of 2 quarters · filed 2025-05-13 | $1.36M derived: sum of 3 quarters · filed 2025-05-13 | $1.71M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $402.26K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $714.09K derived: sum of 2 quarters · filed 2025-03-31 | $1.06M derived: sum of 3 quarters · filed 2025-03-31 | $1.49M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $311.83K 10-Q · filed 2024-11-13 | $661.49K derived: sum of 2 quarters · filed 2024-11-13 | $1.08M 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | $349.66K 10-Q · filed 2024-08-08 | $771.54K 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | $421.89K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |